Brain cancer is the deadliest childhood cancer, claiming more young lives than any other disease. For families, a diagnosis is devastating. But now, thanks to a global research collaboration, hope is on the horizon. PNOC Foundation is embarking on its most ambitious initiative yet: Lose No Child — a bold $50 million fundraising campaign launching September 1st to speed research, expand access to clinical trials, and deliver safer, more effective treatments to children everywhere.
The Grady family’s world changed in an instant when their 22-month-old daughter, Courtney, was diagnosed with a brain tumor. But thanks to her extraordinary care at UCSF, Courtney is now a thriving, healthy 6-year-old. PNOC’s goal is urgent and clear: to achieve in five years what might otherwise take a decade. As part of the campaign’s launch, the Gradys give back by sharing their powerful story in a new video.
While searching for ways to give back, Kelsey and Michael Grady, Courtney’s parents, found the PNOC Foundation through a Marin Magazine article. Remarkably, the article also introduced them to a groundbreaking global research effort led by the very doctors who had saved their daughter’s life.
Inspired, Kelsey and Michael connected with Bruce and Allyn Campbell, who founded the PNOC Foundation after their son George was diagnosed with a brain tumor. The Campbells now lead fundraising for the Pediatric Neuro-Oncology Consortium (PNOC), the bold and innovative international research and clinical trials collaboration founded by Dr. Sabine Mueller and Dr. Michael Prados.
From their base at UCSF Benioff, PNOC brings together over 300 of the world’s leading researchers and clinicians across 42 institutions, all working to accelerate breakthroughs in pediatric brain cancer. Since its inception, the PNOC Foundation has helped raise more than $25 million to support this vital mission.
Childhood cancer research is poised for revolutionary innovation. New discoveries in genetics, immunotherapy and biochemistry combined with artificial intelligence, advancements in imaging and gene editing technology will drive unprecedented breakthroughs. With thirteen new clinical trials launching this year — and a recent FDA approval of a new at-home therapy — PNOC’s momentum is accelerating.
“There’s never been a more hopeful time to invest in pediatric brain cancer research,” says Bruce Campbell, founder of PNOC Foundation. “Public and philanthropic support for this bold campaign will ensure we reach a future where we lose no child to brain cancer — faster.”
Kelsey Grady emphasized, “We’re calling on parents and families nationwide to join us — donate, get involved, and help us reach the Lose No Child campaign goal. Together we have the power to redefine the pace of progress in the fight against the deadliest childhood cancers.”
To learn more and support this campaign PNOC Foundation invite you to visit Losenochild.org
